MeSH term
Frequency | Condition_Probility | Animals | 14 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Humans | 27 | 0.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Mice | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Transfection | 8 | 0.0 |
Comparative Study | 4 | 0.0 |
Vascular Cell Adhesion Molecule-1/blood | 2 | 3.0 |
Cell Adhesion Molecules/*analysis | 5 | 4.0 |
Female | 6 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Male | 6 | 0.0 |
Middle Aged | 5 | 0.0 |
Tumor Necrosis Factor-alpha/*analysis | 2 | 0.0 |
Rats | 2 | 0.0 |
Base Sequence | 7 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Vascular Cell Adhesion Molecule-1 | 9 | 10.0 |
Blotting, Northern | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Adult | 4 | 0.0 |
Cell Line | 5 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Inflammation/metabolism | 2 | 2.0 |
Biological Markers | 3 | 0.0 |
Cell Adhesion Molecules/*genetics | 2 | 2.0 |
DNA/genetics/isolation & purification | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Acute Disease | 2 | 0.0 |
Alkaline Phosphatase/analysis | 2 | 3.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Antigens, CD/*analysis | 2 | 0.0 |
Bone Marrow/*pathology/physiology | 2 | 66.0 |
*Bone Marrow Cells | 2 | 0.0 |
Hematopoietic Stem Cells/*cytology/*pathology/physiology | 2 | 100.0 |
Leukemia, Myeloid/*pathology | 2 | 3.0 |
Macrophages/cytology/pathology | 2 | 66.0 |
Reference Values | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Genotype | 3 | 0.0 |
Risk Factors | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Ligands | 2 | 0.0 |
Lipolysis | 2 | 2.0 |
Models, Biological | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Vascular Cell Adhesion Molecule-1/biosynthesis | 2 | 5.0 |
Amino Acid Substitution | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
